Dexcom (DXCM) FY2024 results: revenue $4.0 billion, up 11.3% on the year
Dexcom Inc. (DXCM) reported revenue of $4.0 billion for fiscal 2024, the year ended 31 December 2024, up 11.3% on the year before. Net income was $576 million, up 6.4%, and diluted earnings per share $1.42. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2025.
Revenue
$4.0 billion
+11.3% on the year
FY2017FY2024
Operating margin
14.9%
16.5% a year earlier
FY2017FY2024
Net income
$576 million
+6.4% on the year
FY2017FY2024
Diluted EPS
$1.42
+9.2% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
990
748
670
+32.2%
Capital expenditure
359
237
365
+51.6%
Free cash flow
631
512
305
+23.2%
Free cash flow margin
15.6%
14.1%
10.5%
Cash from investing
-208
-507
-522
Cash from financing
-735
-319
-552
Depreciation and amortisation
218
186
156
+17.0%
Share-based compensation
170
151
126
+13.0%
Buybacks
750
689
558
+8.9%
Diluted shares, weighted
413m
426m
428m
-3.0%
Shares outstanding at period end
391m
385m
386m
+1.4%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
2,103
2,069
2,132
+1.6%
Debt
2,441
2,434
1,970
+0.3%
Operating lease liabilities
65.0
80.1
94.6
-18.9%
Finance lease liabilities
58.5
58.6
59.6
-0.2%
Other liabilities
1,817
1,623
1,135
+12.0%
Total liabilities and equity
6,484
6,264
5,392
+3.5%
Fixed assets
n/a
n/a
1,056
Goodwill
22.8
25.2
25.7
-9.5%
Intangible assets
103
134
173
-23.1%
Investments
1,849
2,198
1,829
-15.9%
Cash and equivalents
606
566
642
+7.0%
Receivables
1,006
974
713
+3.3%
Inventory
543
560
307
-3.0%
Other assets
2,355
1,806
646
+30.3%
Total assets
6,484
6,264
5,392
+3.5%
10-K for the year ended 31 December 2024, filed 18 February 2025: the filing.